Suraj Mudichintala

Suraj Mudichintala

Directeur/Membre du Conseil chez
Axon Therapies, Inc.
Consumer Services
Finance
Health Technology

Profil

Suraj Mudichintala is a senior associate at APVC in Santa Cruz, CA. He represents APVC on the Boards of Alpheus Medical, Axon Therapies and Onc.ai.
He was previously an investor at Arboretum Ventures, where he served as a Board observer at Allay Therapeutics, Avation Medical, Francis Medical, Health Scholars, Koya Medical, and RareCyte.
Prior to investing, Suraj was an associate with L.E.K.
Consulting, a global strategy consulting firm.
While at L.E.K., Suraj completed ~20 engagements predominantly for life sciences and private equity clients.
Suraj graduated cum laude with a B.S.
in Finance and Analytics from Boston College.
Suraj previously served on the Michigan Translational Research and Commercialization (MTRAC) Oversight Committee for Medical Devices, where he provided guidance to Michigan higher education researchers on transitioning their early stage products to the private sector for commercialization.

Postes actifs de Suraj Mudichintala

SociétésPosteDébut
Analyste en capital-investissement 01/01/2018
Analyste en capital-investissement 01/06/2022
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Formation de Suraj Mudichintala

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

81

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Consumer Services

Finance

Consumer Services

Health Technology

Health Services

Technology Services

Finance

  1. Bourse
  2. Insiders
  3. Suraj Mudichintala
🔇